These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21714676)

  • 1. Metabolic clearance rate is a more robust and physiological parameter for insulin sensitivity than glucose infusion rate in the isoglycemic glucose clamp technique.
    Tajiri Y; Sato S; Yamada K
    Diabetes Technol Ther; 2011 Oct; 13(10):1057-61. PubMed ID: 21714676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study to evaluate surrogate markers of insulin resistance in forty euglycemic healthy subjects.
    Gupta AK; Jain SK
    J Assoc Physicians India; 2004 Jul; 52():549-53. PubMed ID: 15645980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range.
    Jani R; Molina M; Matsuda M; Balas B; Chavez A; DeFronzo RA; Abdul-Ghani M
    Diabetes Care; 2008 Feb; 31(2):311-5. PubMed ID: 18000182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report.
    Ohkura T; Shiochi H; Fujioka Y; Sumi K; Yamamoto N; Matsuzawa K; Izawa S; Kinoshita H; Ohkura H; Kato M; Taniguchi S; Yamamoto K
    Cardiovasc Diabetol; 2013 Jan; 12():21. PubMed ID: 23339473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects.
    Anderwald C; Anderwald-Stadler M; Promintzer M; Prager G; Mandl M; Nowotny P; Bischof MG; Wolzt M; Ludvik B; Kästenbauer T; Pacini G; Luger A; Krebs M
    Diabetes Care; 2007 Sep; 30(9):2374-80. PubMed ID: 17595351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin detemir under steady-state conditions: no accumulation and constant metabolic effect over time with twice daily administration in subjects with Type 1 diabetes.
    Bott S; Tusek C; Jacobsen LV; Endahl L; Draeger E; Kapitza C; Heise T
    Diabet Med; 2006 May; 23(5):522-8. PubMed ID: 16681561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary study on characteristics of insulin secretion rate, metabolic clearance rate and sensitivity in non-insulin-dependent diabetic subjects from multiplex diabetic pedigrees].
    Ran J; Cheng H; Li F
    Zhonghua Yi Xue Za Zhi; 2000 Jan; 80(1):38-41. PubMed ID: 11798736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover study.
    Cernea S; Kidron M; Wohlgelernter J; Raz I
    Clin Ther; 2005 Oct; 27(10):1562-70. PubMed ID: 16330292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of simple indices of insulin sensitivity using the euglycemic hyperinsulinemic clamp technique.
    Straczkowski M; Stepień A; Kowalska I; Kinalska I
    Med Sci Monit; 2004 Aug; 10(8):CR480-4. PubMed ID: 15277999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential infusions of glucose and insulin at prefixed rates: a simple method for assessing insulin sensitivity and insulin responsiveness.
    Heine RJ; Bilo HJ; van der Meer J; van der Veen EA
    Diabetes Res; 1986 Nov; 3(9):453-61. PubMed ID: 3549121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarity of pharmacodynamic effects of a single injection of insulin glargine, insulin detemir and NPH insulin on glucose metabolism assessed by 24-h euglycaemic clamp studies in healthy humans.
    Sørensen LP; Brock B; Mengel A; Rungby J; Moller N; Nielsen S; Vølund A; Schmitz O
    Diabet Med; 2010 Jul; 27(7):830-7. PubMed ID: 20636965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in insulin action after a single bout of exercise.
    Perreault L; Lavely JM; Bergman BC; Horton TJ
    J Appl Physiol (1985); 2004 Sep; 97(3):1013-21. PubMed ID: 15145925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring insulin sensitivity in postmenopausal women covering a range of glucose tolerance: comparison of indices derived from the oral glucose tolerance test with the euglycemic-hyperinsulinemic clamp.
    Piché ME; Lemieux S; Corneau L; Nadeau A; Bergeron J; Weisnagel SJ
    Metabolism; 2007 Sep; 56(9):1159-66. PubMed ID: 17697856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes.
    Klein O; Lynge J; Endahl L; Damholt B; Nosek L; Heise T
    Diabetes Obes Metab; 2007 May; 9(3):290-9. PubMed ID: 17391154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of liver fat on insulin clearance.
    Kotronen A; Vehkavaara S; Seppälä-Lindroos A; Bergholm R; Yki-Järvinen H
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1709-15. PubMed ID: 17895288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of insulin treatment on insulin sensitivity in insulin requiring type 2 diabetes patients.
    Mayorov AY; Naumenkova IV; Antsiferov MB; Dedov II
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S54-9. PubMed ID: 15955377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance in patients with type 1 diabetes assessed by glucose clamp studies: systematic review and meta-analysis.
    Donga E; Dekkers OM; Corssmit EP; Romijn JA
    Eur J Endocrinol; 2015 Jul; 173(1):101-9. PubMed ID: 25899581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients.
    Miyazaki Y; Glass L; Triplitt C; Matsuda M; Cusi K; Mahankali A; Mahankali S; Mandarino LJ; DeFronzo RA
    Diabetologia; 2001 Dec; 44(12):2210-9. PubMed ID: 11793023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of obesity on insulin action in NIDDM.
    Campbell PJ; Carlson MG
    Diabetes; 1993 Mar; 42(3):405-10. PubMed ID: 8432411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.